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Abstract
Background:  Portal hypertension leads to the formation of portosystemic collateral veins in liver
cirrhosis. The resulting shunting is responsible for the development of portosystemic encephalopathy.
Although ammonia plays a certain role in determining portosystemic encephalopathy, the venous ammonia
level has not been found to correlate with the presence or severity of this entity. So, it has become partially
obsolete. Realizing the need for non-invasive markers mirroring the presence of esophageal varices in
order to reduce the number of endoscopy screening, we came back to determine whether there was a
correlation between blood ammonia concentrations and the detection of portosystemic collateral veins,
also evaluating splenomegaly, hypersplenism (thrombocytopenia) and the severity of liver cirrhosis.
Methods: One hundred and fifty three consecutive patients with hepatic cirrhosis of various etiologies
were recruited to participate in endoscopic and ultrasonography screening for the presence of
portosystemic collaterals mostly esophageal varices, but also portal hypertensive gastropathy and large
spontaneous shunts.
Results: Based on Child-Pugh classification, the median level of blood ammonia was 45 mcM/L in 64
patients belonging to class A, 66 mcM/L in 66 patients of class B and 108 mcM/L in 23 patients of class C
respectively (p < 0.001).
The grade of esophageal varices was concordant with venous ammonia levels (rho 0.43, p < 0.001). The
best area under the curve was given by ammonia concentrations, i, e., 0.78, when comparing areas of
ammonia levels, platelet count and spleen longitudinal diameter at ultrasonography. Ammonia levels
predicted hepatic decompensation and ascites presence (Odds Ratio 1.018, p < 0.001).
Conclusion: Identifying cirrhotic patients with high blood ammonia concentrations could be clinically
useful, as high levels would lead to suspicion of being in presence of collaterals, in clinical practice of
esophageal varices, and pinpoint those patients requiring closer follow-up and endoscopic screening.
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Background
Portal hypertension leads to the formation of portosys-
temic collateral veins, of which Esophageal Varices (EV)
have the greatest clinical impact and the most severe com-
plications. Specifically, they are discovered on endoscopy
in up to two thirds of decompensated cirrhotics. The pos-
sibility of identifying cirrhotic patients with EV or other
collateral presence by non-invasive means is appealing, in
that it could decrease the necessity of endoscopic screen-
ing with reduced healthcare costs. The acceptability of
such markers depends mainly on their false-negative rate,
i.e., those patients with EV and increased risk of bleeding
who are not detected because of exclusion from endo-
scopic screening. Increased spleen volume is an independ-
ent predictor of large EV in liver cirrhosis [1], although, a
study by Burton et al. casts some doubt on its validity [2].
So far, several studies addressing this issue have been per-
formed with varying success. They have either been based
on laboratory parameters, i.e. platelets count (PLTS) or
UltraSonographic (US) features [3-10], of which the most
interesting seems to be the Spleen Longitudinal Diameter
(SLD). Other manifestations of portal hypertension
include Portal Hypertensive Gastropathy (PHG), [11] and
Large Spontaneous Shunts (LSS). The prevalence of PHG
is high (60–80%), but much less in mild portal hyperten-
sion (22%), [12]. About 8% of the upper digestive haem-
orrhages in the cirrhotic patients are secondary to PHG.
LSS refer to the presence of patent paraumbilical vein,
Spleno-Renal Shunt (SRS), ano-rectosigmoid varices with
or without Portal Hypertensive Colopathy (PHC). The
prevalence of umbilical vein patency ranges from 6% to
30% in patients with portal hypertension [13]. SRS are
present in up to 21% of cirrhotics [14]. Rectosigmoid
varices are present in nearly one third of cirrhotic patients,
4% of whom have a lower gastrointestinal hemorrhage,
[15]. LSS have been shown to be responsible for recurrent
or persistent Portal-Systemic Encephalopathy (PSE), [16].
Actually, ammonia (NH4) levels cannot serve as a labora-
tory marker for PSE, being neither specific nor highly sen-
sitive [17], although there may be a correlation with
severity [18]. The diagnosis of PSE is mainly clinical (neu-
ropsychiatric), and may be confirmed by instrumental
measures such as EEG and psychometric testing. This begs
the question of whether the routine testing of ammonia
levels should be abandoned.
The aim of our study was to investigate the diagnostic util-
ity of venous ammonia levels, spleen size and platelet
count as non-invasive markers of shunt presence, with
particular emphasis on esophageal varices, and eventual
hepatic decompesation. We attempted to correlate these
markers with endoscopy findings, US features and Child-
Pugh classification as indices of shunt presence (reference
tests).
Methods
Population
The study included 201 consecutive patients with liver cir-
rhosis admitted to two Liver Units of university/primary
hospitals in Southern Italy, between the period from
October 2004 to June 2007 who fulfilled the following
criteria: patients' willingness to undergo previously estab-
lished screening; endoscopic, US and laboratory examina-
tions performed within four weeks of each other;
prospective follow-up for a minimum period of 6
months.
Of initial patients, 26 were kept out because their US and
laboratory examinations had been previously performed
in different centres. Fourteen patients, who had under-
gone endoscopic esophageal variceal ligation therapy, and
eight who had received beta-blockers before US imaging,
were also excluded from the study because prior treatment
might have caused a change in lesion features.
The remaining 153 patients formed the study population
(85 males) whose age ranged from 31 to 85 years (median
age 66 years). Chronic liver damage in these patients was
caused by hepatitis B (n = 9), hepatitis C (n = 114), alco-
hol abuse (n = 20) or unknown etiology, likely NonAlco-
holic Steato Hepatitis (NASH), (n = 8). Ninety two
patients had compensated cirrhosis of the liver. For 121
patients, the diagnosis of cirrhosis was established by con-
textual clinical (spider nevi, organomegaly) laboratory
(low total cholesterol and pseudocholinesterase levels,
reduced white blood cell count, globulin/albumin ratio >
1), antecedent imaging data and for 32 patients by biopsy.
The non-invasive assessment of liver cirrhosis was blindly
performed de novo to all patients by radiologists on the
basis of US/US-doppler examinations (coarse echo-tex-
ture, nodularity presence, increased caudate/right lobe
ratio, hypertrophy of the left lobe, characterized by a
rounded inferior marginal edge, and portal vein enlarge-
ment with decreased flow velocity, absence of a normal
doppler waveform, hepatofugal flow). No evidence of
hepatocellular carcinoma at the first hepatic decompensa-
tion was detected. Renal insufficiency was properly
excluded.
Outcome measures
We assessed the reliability of venous ammonia levels, SLD
based on US, and platelet count in predicting the presence
of collateral veins, i.e., EV, PHG, LSS including ano-rectal
varices, PHC, umbilical vein patency and SRS evidenced
by endoscopic and US features.
Endoscopic features
Esophageal Varices
Esophageal varices were graded according to a previous
classification, i.e., F1, small and straight F2, moderatelyBMC Gastroenterology 2009, 9:21 http://www.biomedcentral.com/1471-230X/9/21
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sized, tortuous, and occupying less than one third of the
lumen F3, large, coiled, and occupying one third or more
of the lumen [19].
Portal Hypertensive Gastropathy
PHG was assessed according to the NIEC classification
[20]. Mosaic-like pattern was characterized by the pres-
ence of small, polygonal areas surrounded by a whitish-
yellow depressed border. Red-point lesions were small,
flat, lesions (1 mm in diameter). Cherry-red spots were
red-coloured, round lesions, slightly protruding into the
lumen of the stomach, (2 mm in diameter). Black-brown
spots were irregularly shaped flat spots, black or brown,
persistently present after washing.
Ano-rectal varices and Portal Hypertensive Colopathy
For ethical reasons, only patients who presented with a
history of hematochezia at hospital entry underwent
colonoscopy to track ano-rectal varices to differentiate
from emorroides.
Portal hypertensive colopathy was defined endoscopically
in patients with vascular ectasia (solitary or diffuse), red-
ness, and blue vein [21].
Hepatic encephalopathy grade
Hepatic encephalopathy was graded based on the level of
consciousness, intellectual functions, behaviour and neu-
romuscular functions according to West Haven (W-H) cri-
teria [22]. W-H grade 0 encephalopathy was ascertained as
previously described [23].
Assessment for decompesated liver cirrhosis
All patients underwent clinical/US and laboratory assess-
ment to establish the liver cirrhosis severity, using a mod-
ified Child-Pugh's classification (Table 1) [24]. Liver
decompesation criterion was set at score 8 of Child-Pugh's
classification [25].
Venous ammonia concentration
Venous ammonia levels were quantified according to
enzymatic determination with glutamate dehydrogenase
using rapid and interference-free photometry (340 nm),
and were expressed as mcM/L.
Due to reasons of safety, blood was kept chilled and
immediately sent to the laboratory for determination.
UltraSound features
Spleen measurements of Spleen Longitudinal Diameter
(SLD) were performed by postero-lateral scanning with
the probe footprint aligned along an intercostal space to
provide a longitudinal view of the spleen. The patients
were asked to breathe slowly, taking long breaths – as var-
ying degrees of inspiration and expiration are needed to
optimize splenic visualization – and to roll on the right
side to some extent to aid visualization. At this point, the
maximum length, i.e., the optically greatest overall longi-
tudinal dimension obtained from one of the two poles
was recorded. Given the high variability in detecting
spleen measurements, an US value ≥ 150 mm was chosen
to correspond to splenomegaly.
Other portosystemic collaterals
Umbilical vein patency, i.e. diameter ≥ 3 mm, was easily
detected within the echogenic ligamentum teres hepatis
and was confirmed by color Doppler US.
SRS was detected by the same method. The direction of
blood flow in the collateral vein was also analyzed in each
patient. The Doppler angle used to examine the portal
vein was less than 50° in all examinations.
Ascites presence
When a patient is in a supine position, free fluid tends to
accumulate in the flanks, particularly the superior end of
the right paracolic gutter, and in the pelvis due to the
effects of gravity. These areas were carefully assessed.
Table 1: Child-Pugh classification slightly modified.
Clinic and laboratory data Points for increasing abnormality1
12 3
HE (grade2) None SHE (0), 1–2 3–4
Ascites None at US Mild or controlled by diuretics Present despite diuretics
PT (% of activity)3 > 70 70–40 < 40
Albumin (g/dL) > 3.5 2.8–3.5 < 2.8
Bilirubin (mg/dL) < 2 2–3 > 3
1Scoring system: 5–6 points, grade A; 7–9 points, grade B; 10–15 points, grade C. 2HE: hepatic encephalopathy; Grade 0: sub-clinical hepatic 
encephalopathy, SHE, unravelled by Retain tests A or B; Grade 1: anxiety, irritability, depression, impaired concentration, sleep disturbances; Grade 
2: disorientation, poor short-term memory, disinhibited behavior, drowsiness; Grade 3: somnolence, bizarre behavior, confusion, amnesia, 
paranoia; Grade 4: Coma. 3PT, prothrombin time, also expressed in seconds prolonged < 4; 4–6; > 6, or as INR < 1.7; 1.7–2.3; > 2.3. US: ultra 
soundBMC Gastroenterology 2009, 9:21 http://www.biomedcentral.com/1471-230X/9/21
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Small quantities were sought for around the liver or
spleen surface and in the Morrison's pouch [26].
US also helped determine the presence of peritoneo-pleu-
ral communications.
Statistical Analysis
Variables were expressed as median and range. To analyze
data regarding the Child-Pugh classification groups,
Kruskal-Wallis test was adopted. To better define the pair-
wise comparison, data were log-transformed and man-
aged by the Student-Newman-Keuls test. The chi square
was used to look for differences in the classification sys-
tem and when stratification was needed multiway tables
were generated. Tracking the degree of association
between single parameters, i.e., NH4, ALT, Platelets, EV
grade and SLD, Spearman's rho for non uniform intervals
was used. The relationship between NH4 levels and the
W-H grades of PSE and the eventual prediction was stud-
ied by linear regression. When confronted with the ques-
tion of how accurate a parameter was in identifying
portosystemic collateral veins presence, the discrimina-
tion with relative cut-off or criterion was evaluated using
Receiver Operating characteristic Curve (ROC) analysis,
graphically expressed as Area Under the ROC (AUROC).
Sensitivity (true positive rate), specificity (true negative
rate) were also weighted for the same purpose. Optimal
cut-off was considered the threshold value with the best
specificity/sensitivity.
To predict the presence of portosystemic collateral veins,
hepatic decompesation and ascites presence the logistic
regression (Enter Method) was employed utilizing as
independent variables US values for SLD, platelets count
and blood NH4 concentrations. The same tool was carried
out to predict the large (II and III grade) EV presence by
NH4 concentrations. To assess the independent effect of a
quantitative variable, i.e., NH4, on the prediction of the
PSE grades linear regression analysis was used. The Factor
Analysis was applied to select a subset of variables from a
larger set, based on which original variables have the high-
est correlations with the principal component factors. The
Cattel Scree plot, with relative eigenvalues, was performed
to screen the real factors. Extraction of the main compo-
nents amounted to a variance maximizing (varimax) rota-
tion of the original variable space. To assess uniformity,
serial measurements were performed, and the data were
summarized into two measures, such as: difference last-
first value (%) and Area Under the Curve (AUC), creating
a clustered multiple comparison graph for the observa-
tions.
<Bookmark(4) The concordance correlation coefficient
(ρc), [27], which measures precision and accuracy, was
adopted to evaluate the degree of pair observations at US
in a reduced sample of 21 patients. Statistical analysis was
performed operating on Systat 12 and MedCalc Version
9.4 software packages.
This study was based on physicians' adhesion to common
diagnostic criteria as previously described and was con-
ducted according to guidelines of the International Con-
ference on Harmonization for Good Clinical Practice, in
accordance with the Code of Ethics of the World Medical
Association (Declaration of Helsinki).
Results
The presence of collaterals based on etiology and Child-
Pugh's classification is shown in Table 2.
EV was present in 70 patients (45% of the whole popula-
tion); PHG in 88 cirrhotics (57.5%) and 53 patients had
both EV and PHG (34.7%), while LSS in 15 cirrhotics
(9.8%), without difference for the aetiology, Pearson Chi-
square: 23.672, p = 0.166.
When categorized by Child-Pugh class, splenomegaly,
present in 50 subjects (32.7%), showed quite similar dis-
tribution in relation to the severity of EV, Table 3.
Data of main outcome measures are expresses in Table 4.
NH4 levels in A Child-Pugh group were significantly dif-
ferent from the ones of group B and C, i.e., 45 mcM/L in
64 patients belonging to class A, 66 mcM/L in 66 patients
of class B and 108 mcM/L in 23 patients of class C respec-
tively, p < 0.001, Student-Newman-Keuls.
The W-H grade 0 was detected in 39.8% of our popula-
tion. Ascites was present in 35 out of 61 decompesated
patients (in one of them hydrothorax was displayed) and
in two out of 92 compensed patients (chi square = 61, p <
0.001).
Associations
First of all, EV grade was well correlated with NH4 levels,
i.e., rho 0.43, p < 0.001, explaining the 18.5% of variance.
A significant correlation was evidenced between SLD val-
ues and EV grades, i.e. rho = 0.35, p < 0.0001. The contin-
ued analysis of blood NH4 concentrations highlighted a
significant (p = 0.02) correlation between them and plate-
lets count, i.e. -0.18, although explaining only the 3.2% of
variance; vice versa, no correlation existed with ALT, i.e.,
0.14 (p = 0.06) nor with SLD, i.e., 0.10 (p = 0.2).
An inverse correlation, i.e., rho -0.53 (p = < 0.0001) was
detected between SLD and PLTS count. By detecting the
structure in the relationships among variables (Factor
Analysis), the EV presence showed the highest value, i.e.,
0.716 followed by the classic sign of portal hypertension,BMC Gastroenterology 2009, 9:21 http://www.biomedcentral.com/1471-230X/9/21
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i.e., splenomegaly at US and by the severity of liver cirrho-
sis, weighted as Child-Pug's classification, but not the
PHG evidence, Figure 1. In the same setting, interestingly,
LSS were correlated to the liver cirrhosis aetiology, being
more frequent, but not statistically different, in cryp-
togenic form (chi square for trend 3.1, p = 0.07).
Accuracy and prediction
When comparing ROC curves to classify the collaterals
presence, NH4 levels gave the best AUROC among PLTS
count and SLD at US, significantly superior to the other
ones. The AUROC of NH4 in predicting the EV presence
alone resulted quite similar to that predicting all the
shunts, i.e., 0.75 (95% CI 0.68–0.82; sensitivity 97%, spe-
cificity 43% with the same criterion of 42 mcM/L) versus
0.78, Figure 2. As matter of fact, two out of 70 patients,
with normal NH4 concentrations (28 and 42 mcM/L,
respectively), having certain EV presence, would be
excluded by the endoscopic performance and only one
out 36 patients would have been missed having large
varices if this threshold had been used. The false positive
rate at this cut-off was 28.1%, i.e., 43 patients.The
AUROCs of NH4 levels and the PLTs/SLD ratio similarly
predicted EV existence (0.75 versus 0.73, p = 0.70).
Among the same parameters, ammonia levels predicted
hepatic decompensation and ascites presence (Odds Ratio
1.018, 95% C. I. 1.009–1.028, Std. Coef. 4. 04, p < 0.001
and 1.018, 95% C. I. 1.009–1.027, Std. Coef. 3.92, p <
0.001, respectively). At the same manner, blood NH4
concentrations best predicted the demonstration of porto-
systemic veins, among PLTs and SLD, Table 5. Interest-
ingly, NH4 concentrations gave a clear prediction of large
Table 2: Collaterals tabulated on aetiology and Child-Pugh classification.
Post-viral EV EV EV PHG PHG PHG LSS LSS LSS
CHILD no yes Total no yes Total no yes Total
A 40 18 58 23 35 58 56 2 58
B 27 33 60 22 38 60 54 6 60
C 167 2 5 7 5 2 7
Total 68 57 125 47 78 125 115 10 125
Ethanol
CHILD no yes Total no yes Total no yes Total
A 314 3 1 4 4 0 4
B 661 2 8 4 1 2 9 3 1 2
C 044 2 2 4 4 0 4
Total 91 1 2 0 1 3 7 2 0 1 7 3 2 0
Cryptogenic
CHILD no yes Total no yes Total no yes Total
A 213 3 1 3 2 1 3
B 415 4 1 5 4 1 5
C 000 0 0 0 0 0 0
Total 628 5 3 8 6 2 8
Esophageal Varices (EV), Portal Hypertensive Gastropathy (PHG), Large Spontaneous Shunts, LSS; Pearson Chi-square: 23.672, p = 0.166.
Table 3: Splenomegaly tabulated on severity of esophageal 
variceal and liver cirrhosis.
Child-Pugh Class A
EV grade 0123T o t a l
Splenomegaly - 3 9 7405 0
Splenomegaly + 64321 5
Total 4 5 1 1 726 5
Child-Pugh Class B
Splenomegaly - 2 7 1 0 564 8
Splenomegaly + 1 0 1 0 542 9
Total 37 20 10 10 77
Child-Pugh Class C
Splenomegaly - 11215
Splenomegaly + 02316
Total 13521 1
Splenomegaly absence/presence (rows) by EV, Esophageal Varices 
grade (columns); Pearson's chi square: 202, p = 0.20. Splenomegaly 
was detected by measuring SLD, Spleen Longitudinal Diameter at US, 
with a value set at ≥ 150 mm.BMC Gastroenterology 2009, 9:21 http://www.biomedcentral.com/1471-230X/9/21
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varices (Odds Ratio 1.012, 95% C. I. 1.004–1.020, Std.
Coef. 0.012, p < 0.002, with 96.6 and 2.78% of correct
diagnosis in absence/presence of their detection (on the
whole 74.5%).
Ammonia levels did not predict severity of PSE measured
as W-H grades, i.e., coefficient = 5.04, beta = 0.088, p =
0.28.
Uniformity
To asses if blood ammonia concentrations of cirrhotic
patients were constant on time, eight of them were stud-
ied at a two week-distance for one month and half. The
results showed a low difference of the remaining values
versus the first one and a near flat AUC, as evidenced in
Figure 3.
The agreement of US paired observations ranked high,
i.e., ρc = 0.91.
Discussion
Authorities give emphasis on following facts: j) the issue
of identifying patients with EV at risk of bleeding by non
invasive means is relevant and has been addressed in sev-
eral recent studies – this research is yet another attempt to
achieve this goal – jj) the timing of endoscopic evaluation
is basic because hemorrhage from EV threatens the
patient's life.
Commenting on the results, we can observe that our data
in cirrhotic patients support a good association between
blood NH4 levels and EV presence. As matter of fact, the
blood ammonia determination suffers from some limits
in its measurements. In fact, the collection, handling, stor-
age, and analysis of blood samples are all potential
sources of error. Anyway, recommendations ought to be
made on the collection and processing of blood samples,
for it is by standardization and rigid adherence to these
techniques that the reliability of the test results will be
improved. The utility of such a marker as the proposed
one relies on easily repeatability, but no way it should
substitute endoscopy screening.
Our data somehow agree with the body of present knowl-
edge. In fact, when comparing the performance of blood
ammonia with the PLTs/SLD ratio [9], the only marker
contextually studied, we found a not so much dissimilar
reliability. The advantages of the Plts/SLD ratio are evi-
dent because they do not suffer from external confound-
ing factors. The disadvantages are consistent with the fact
that thrombocytemia is sometime related to the auto-anti-
bodies presence that turns out in falsely low count of
PLTs. Indeed, the opposite, falsely high count of PLTs,
could be detected in patients suffering from liver cirrhosis
with hepatocarcinoma.
We think that the key point is not whether to recommend
endoscopy or not but when to undergo it. Decision about
the optimal intervals for surveillance mainly to detect
large varices depends on what proportion of patients that
bleeds before starting prophylactic treatment we are will-
ing to accept. If we set the acceptable level of risk at 10%,
patients with no varices at baseline can be re-endoscoped
at 3-year intervals; for patients with small varices at base-
line, the recommended interval of 1–2 years [27] R. de
Franchis, Updating consensus in portal hypertension:
report of the Baveno III consensus workshop on defini-
tions, methodology and therapeutic strategies in portal
hypertension, J. Hepatol. 33 (2000), pp. 846–852. should
be maintained [28]. According to our results, patients
with high levels of NH4 should undergo endoscopy faster.
As preliminary remark, we admit that in determining por-
tal hypertension, mechanisms potentially reversible are
involved, i.e., contractility of sinusoidal lining cells, sys-
temic mediators of arteriolar resistance, production of
endothelins or nitric oxide, and swelling of hepatocytes
[29]. However, other irreversible factors such as tissue
Table 4: Main outcome measures tabulated on liver cirrhosis severity.
Child-Pugh Class
ABC
N Median Minimum Maximum N Median Minimum Maximum N Median Minimum Maximum
NH4
mcM/L
64 45 19 183 66 66 31 221 23 108 28 258
PLTs
mmc/mL
64 115,000 42,000 293,000 66 86,400 30,000 312,000 23 62,250 27,600 137,000
SLD
mm
64 133 103 205 66 146 110 212 23 159 100 210
NH4 Ammonia; PLTs, Platelets count; SLD, Spleen Longitudinal Diameter. NH4 best differentiated groups, see Figure 1; PLTS differentiated only 
group A from B, p = 0.013; SLD differentiated only Group A from B, p = 0.24BMC Gastroenterology 2009, 9:21 http://www.biomedcentral.com/1471-230X/9/21
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Hidden relationships unravelled by the Factor Analysis Figure 1
Hidden relationships unravelled by the Factor Analysis. Percent of Total Variance Explained by factors: 1 (24.4); 2 
(16.3); NH4, Ammonia; PLTs, Platelets count; SLD, Spleen Longitudinal Diameter; EV, Esophageal Varices; PHG, Portal Hyper-
tensive Gastropathy; LSS, Large Spontaneous Shunts; ALT, ALanin Transferase; the critical value was calculated by the formula: 
Pearson's correlation coefficient for 1% level of significance/square root of patients minus 2, i.e., 419.
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Comparison of ROC curves using as classification variable the presence of Collaterals Figure 2
Comparison of ROC curves using as classification variable the presence of Collaterals. NH4, Ammonia; PLTs, 
Platelets count; SLD, Spleen Longitudinal Diameter; NH4 cut-off (42 mcM/L) had sensibility of 92% and specificity of 60%, with 
8% of false negative results; CI, Confidence Intervals.
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fibrosis and regeneration increase resistance in the sinu-
soids and terminal portal venules, playing a key role. Even
though PHG is recognized as a clinical entity associated to
portal hypertension, its significance has not yet been elu-
cidated [30].
Discussing possible mechanisms and explanations for our
findings, it is noteworthy to stress the fact that portal
hypertension contributes slowly but constantly to hepatic
insufficiency. Our observation that blood NH4 levels pre-
dicted both ascites and collaterals presence is intriguing,
reinforcing the concept of a common origin. Data from
long follow-up of patients suffering from compensated
cirrhosis B show that poor hepatic reserve and severity of
portal hypertension significantly correlate [31]. At the
same manner, measurements of portal pressure provide
unique prognostic information for predicting portal
hypertensive-related bleeding and mortality in patients
with alcoholic cirrhosis [32], also in patients without clear
presence of EV [33]. High values of blood NH4 are impor-
tant because they point out an incoming liver decompesa-
tion; in fact, less blood reaches the liver, diminishing thus
the hepatic reserve. Portal-systemic collaterals provide a
pathophysiological route to decompress the hypertensive
portal system. Despite this, the vascular resistance of the
collateral bed is still greater than the resistance of the liver,
and portal pressure does not decrease [34]. What is more,
ammonium compounds increase vascular tone by causing
influx of extracellular calcium through the voltage-
dependent calcium channel and intracellular alkalinisa-
tion [35]. The opposite effect (depleting intracellular
Ca2+ stores on flow-induced vascular dilatation) was
proved in rat isolated small mesenteric arteries [36].
Examining the limitations of the present study we have to
pinpoint that as indirect evidence of portosystemic shunts
presence, some laboratory parameters have already been
proposed, i.e., Serum Bile Acids (SBA) and Indocyanine
Green Clearance (IGC). Portosystemic shunting in dogs
occurs frequently either as congenital anomalies of the
portal vein or as acquired shunting due to portal hyper-
tension secondary to parenchymal liver disease or portal
vein thrombosis. In these animals, the two most com-
monly used screening tests for detecting shunts are SBA
and plasma ammonia concentrations. Both are reliable,
but blood ammonia level is a higher sensitive and specific
parameter [37]. Following this evidence, we might have
dosed the SBA levels, to confirm our hypothesis, and
probably post-prandial rather than fasting SBA values, but
this test is subject to some limitations. In fact, impaired
hepatic uptake could be the major determinant of the rise
in SBA levels in chronic liver disease [38]. Secondly, high
SBA values have been reported in patients with small
bowel colonisation [39]; abnormal SBA concentrations
have been described in hyperlipidaemia [40], and chang-
ing SBA status has been noted with alteration of the die-
tary vitamin C [41]. IGC, measured by percentage
disappearance rate, detects alterations in liver function
[42]. Given that these disappearance rates (percentage)
have been found to correlate with Child's-Pugh scores in
a series of cirrhotic patients [43], it is likely that blood
ammonia levels and IGC provide similar assessments of
the severity of hepatic decompesation.
Further drawbacks to our study could be unreported vari-
ation of diet (hyperproteic) by patients and missed occult
Table 5: Prediction of Esophageal Varices and collaterals.
a 95% C. I.
Parameter p-value Odds Ratio Lower Upper
NH4 < 0.001 1.017 1.0075 1.027
PLTs 0.03 1.001 1 1.001
SLD 0.4 0.985 0.95 1.016
PLTs/SLD 0.012 0.99 0.98 0.99.8
b 95% C. I.
Parameter p-value Odds Ratio Lower Upper
NH4 < 0.001 1.023 1.010 1.035
PLTs 0.085 0.994 0.986 1.001
SLD 0.233 1.011 0.993 1.028
Logistic regression using Esophageal Varices (a) and collaterals (b) 
presence as dependent variable; NH4 Ammonia; PLTs, Platelets 
count; SLD, Spleen Longitudinal Diameter; PLTs/SLD, Platelets count 
Spleen Longitudinal Diameter ratio index.
Serial measurements Figure 3
Serial measurements. Clustered multiple comparison 
graph showing a good repeatability of blood ammonia con-
centration over time; median of the maximum difference ver-
sus first value percentage = -22.5, 95% C.I. -29.74 to 12.4; 
median of the AUC, (baseline = first value) = -577.5, C.I. = -
1027.76 to 229.84; AUC, Area Under the Curve.
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blood loss. Our repeated measure of blood NH4 did not
significantly change, thus minimizing the possibility of
hyperproteic diet influence on ammonia levels. A further,
more important, disadvantage could be represented by
the temporary use of non-absorbable disaccharides by 18
out of 23 decompesated patients. In fact, although there is
some criticism about their being of benefit to lower NH4
[44], they are still considered standard treatment for PSE.
Clearly, Child's-Pugh classification is not studied as a risk
factor for shunting, because internal and external validity
may be compromised as some predictors may not be inde-
pendent of each other or of outcomes. Colonoscopy was
not offered to every patient. Finally, although detection of
other portosystemic collaterals besides EV improves the
specificity of NH4, it is barely important in clinical prac-
tice as prophylactic remedies are not warranted. On the
contrary, our figures are corroborated by previous data
speculating on hyperintense globus pallidus on T1-
weighted cranial magnetic resonance imaging [45].
Conclusion
Identifying cirrhotic patients having high ammonia levels
could be useful, as they lead the treating physician to sus-
pect an eventual presence of collaterals, mainly esopha-
geal varices. This would encourage the use of endoscopy
screening in this at-risk population, and increase the phy-
sicians' surveillance for ascites and/or PSE. Although
some data are expected, this study is the first to demon-
strate on a sufficiently large scale the strict correlation
between NH4 levels and portosystemic collateral chan-
nels that carry blood away from the portal venous system
to the general circulation. But, are these efforts worth to?
In fact, for some Authorities, in primary prophylaxis of
variceal bleeding, as first strategy, patients should be given
a beta-blocker without undergoing upper endoscopy [46].
Anyway, this issue still remains unsolved because this
practice is associated with increased adverse effects, such
as hypotension, and minimal reduction in mortality.
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